ESR1 and glaucoma: Therefore, potential therapies aimed to minimize off-target effects of estrogen therapy or exploit specific central nervous system estrogen receptor targets could provide a multi-faceted approach to glaucoma management (Wei et al. 2012; Prokai-Tatrai et al. 2013; Prokai et al. 2015; Prokai-Tatrai and Prokai 2019).